ROSH Pulmonology UPDATED ACTUAL Questions and CORRECT Answers
1. Empiric treatment of CAP <65 Amoxicillin or Macrolide or Doxycycline
year old and no comorbidities
2. Empiric treatment of CAP >65 Amoxicillin or Augmentin
year old and with comorbidities +
Doxycycline or Macrolide
or Fluroquinolone
3. Working in shipbuilding, con- Asbestosis
struction or plumbing put you
at increased risk of
4. Primary causes of transudative HF (most common)
pleural effusion Cirrhosis
Most common is Pulmonary embolism
Nephrotic Syndrome
5. Light criteria for pleural effu-
sion
Pleural: serum protein
Pleural: serum LDH
Pleural fluid
6. Characteristic physical finding Diminshed breath sounds
of pneumothorax are Decreased or absent tactile fremitus
Hyperresonance to percussion
7. Needle thoracostomy location 1. Second intercostal space midclavicular line
2. 4th or 5th anterior axillary line
8. Sarcoidosis
, Uveitis, bilateral hilar adenopa-
thy, dry cough, subcutaneous
nodules (i.e., erythema no-
dosum), and an elevated ery-
throcyte sedimentation rate
most likely suggest
9. Treatment of sarcoidosis Corticosteroids
10. Pathognomonic finding of sar- Lupus Pernio (chronic, violaceous, raised plaques and nod-
coidosis ules commonly found on the cheeks, nose and around the
eyes
11. Labs findings associated with Hypercalcemia, hypercalciuria, elevated serum ACE
sarcoidosis
12. Most common cause of bronchi- RSV
olitis
13. Treatment of bronchiolitis Supportive care
14. Triad of hilar adenopathy + ery- Lofgren Syndrome
thema nodosum + polyarthral-
gia =
15. Classification of intermittent Symptoms d2days/week
asthma
d2nighttime awakenings/month
16. Classification of mild persistent Symptoms > 2 days/week but not daily
asthma
3-4 nighttime awakenings/month
FEV1 e80% of predicted
, 17. Classification of moderate per- Symptoms daily
sistent asthma
> 1 nighttime awakening/week but not nightly
FEV1 60-80% of predicted
18. Classification of severe persis- Symptoms throughout the day
tent asthma
Nightly awakenings common
FEV1 < 60% of predicted
19. Acute respiratory distress syn- accumulation of fluid in the alveolar spaces.
drome (ARDS) is an acute lung
injury due to the
20. Risk factors for spontaneous tall, thin males
pneumothorax
21. Findings is most suggestive of Elevated serum LDH
Pneumocystis jirovecii pneumo-
nia in a patient with suspected
HIV infection and shortness of
breath?
22. Treatment of Pneumocystis Bactrim
jirovecii pneumonia
23. The most common cause of viral
pleuritic chest pain is
24. PE of pleural effusion Decreased breath sound + dullness to percussion + de-
creased tactile fremitus
1. Empiric treatment of CAP <65 Amoxicillin or Macrolide or Doxycycline
year old and no comorbidities
2. Empiric treatment of CAP >65 Amoxicillin or Augmentin
year old and with comorbidities +
Doxycycline or Macrolide
or Fluroquinolone
3. Working in shipbuilding, con- Asbestosis
struction or plumbing put you
at increased risk of
4. Primary causes of transudative HF (most common)
pleural effusion Cirrhosis
Most common is Pulmonary embolism
Nephrotic Syndrome
5. Light criteria for pleural effu-
sion
Pleural: serum protein
Pleural: serum LDH
Pleural fluid
6. Characteristic physical finding Diminshed breath sounds
of pneumothorax are Decreased or absent tactile fremitus
Hyperresonance to percussion
7. Needle thoracostomy location 1. Second intercostal space midclavicular line
2. 4th or 5th anterior axillary line
8. Sarcoidosis
, Uveitis, bilateral hilar adenopa-
thy, dry cough, subcutaneous
nodules (i.e., erythema no-
dosum), and an elevated ery-
throcyte sedimentation rate
most likely suggest
9. Treatment of sarcoidosis Corticosteroids
10. Pathognomonic finding of sar- Lupus Pernio (chronic, violaceous, raised plaques and nod-
coidosis ules commonly found on the cheeks, nose and around the
eyes
11. Labs findings associated with Hypercalcemia, hypercalciuria, elevated serum ACE
sarcoidosis
12. Most common cause of bronchi- RSV
olitis
13. Treatment of bronchiolitis Supportive care
14. Triad of hilar adenopathy + ery- Lofgren Syndrome
thema nodosum + polyarthral-
gia =
15. Classification of intermittent Symptoms d2days/week
asthma
d2nighttime awakenings/month
16. Classification of mild persistent Symptoms > 2 days/week but not daily
asthma
3-4 nighttime awakenings/month
FEV1 e80% of predicted
, 17. Classification of moderate per- Symptoms daily
sistent asthma
> 1 nighttime awakening/week but not nightly
FEV1 60-80% of predicted
18. Classification of severe persis- Symptoms throughout the day
tent asthma
Nightly awakenings common
FEV1 < 60% of predicted
19. Acute respiratory distress syn- accumulation of fluid in the alveolar spaces.
drome (ARDS) is an acute lung
injury due to the
20. Risk factors for spontaneous tall, thin males
pneumothorax
21. Findings is most suggestive of Elevated serum LDH
Pneumocystis jirovecii pneumo-
nia in a patient with suspected
HIV infection and shortness of
breath?
22. Treatment of Pneumocystis Bactrim
jirovecii pneumonia
23. The most common cause of viral
pleuritic chest pain is
24. PE of pleural effusion Decreased breath sound + dullness to percussion + de-
creased tactile fremitus
